Stocks to Watch: Aptose Biosciences Inc. (TSX:APS) Up +4.76%

At close of market on Tuesday, Aptose Biosciences Inc. (TSX:APS) stock finished trading at +4.76%, bringing the stock price to $3.08 on the Toronto Stock Exchange. The stock price saw a low of $2.90 and a high of $3.13.

The company’s stock was traded 418 times with a total of 75,064 shares traded.

Aptose Biosciences Inc. has a market cap of $170.74 million, with 53.19 million shares in issue.

Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.

error: Content is protected !!